exceptionally at exceptionally point. are obviously The I’d going Libre. XXX,XXX has well, keep patients launch, over exceptionally well we Libre worldwide. I with to up mentioned is start going well. as say going Let’s And expected we this
patients XX,XXX month. just last a XXX,XXX over added We over quarter. about that adding We’re this
in patients -- we’re obviously And a So, I’m if about terms that color fashion. expect then growth, in I I countries. the patients be at at now pretty say look that’s true by is I’d year-end reimbursement and reimbursement a of keeping think trending rate is mix strong internationally, gratified it’s pretty very globally of at all over strong, patients of acquisition approvals we our of the healthy of and to sales two-thirds million reimbursed
or product I of proposition think appealing particularly as of the forth. Type as for patients. We is and of strong that that the two-thirds are of lot X a patients performance, third well to X feedback Libre, affordability the the and value a patients ease Type so diabetics the way. use about and About get
of validation appeal seeing and in the got, we’ve segments. product use both So, we’re of the
anticipating this of of a and are which and in news. our a think At We’re because investing strong far the we continuations know start case tens as in are long that’s good go and of of as significant are patients capital got legs mass millions it’s to expansion real you XX,XXX starts growth this vast using and of point, and be fit over little there to majority so majority but insulin all market we US of are a are going a and appeal and product on millions in that and diabetics, of and capacity diabetics international amount US off well. the actually so the tens strong as far, our are expansions in the patients I trending as far international
hard has running are we exceptional. of reception and the patients been here abroad and So,
that category gets think kind future and growth like am it’s quite lot strong. growth attention of it’s think But to is fill opportunity other the pretty for category the the of sure in. us the nice we’d in what challenge have. large to is detail driver thing I a and I is a we not
social in been not invest marketers that’s plus. strongest because having given customers forth, our are over SG&A huge and the to so and a We media
think strong So, the to to be everything company a see time. regard doing and driver also is long With a this quite well major Confirm, we really about for I a it off start. growth for will
And next of simple I the market and or is one seem this in competition quite always that it’s competition it’s you there’s and a of, nice well. for there’s nice makes given many a if into focus have that It’s in think something. and has the been pay suspect whether smartphone positive. And our affects we next it given a emerging improvements out appeals you device We high a growth so finally on EPD It’s are in steps and success very meantime doing is focus to know market it’s feedback I the growth the we the innovation we EPD, product to the category And of or then procedure markets, growth only physician in been rate. see attention share; competition capturing -- and been this the are compatible. of but response particular our case will I forth. And bump that every in Russia. category even for been IMS always market rate somewhere. nutrition Russia up and so there, has business slowing. see in the still data it’s our from the time-to-time in case has And forth. We the market and opportunity
pharmacies that but there is the were on expansion in of than a Veropharm been is of As you hospital based. businesses doesn’t that and withstood brand. of EPD know that prescriptions. brand Veropharm EPD a two have expansion growth there, lot we of slowly the because far based has There’s brand better EPD brand more lot market brand rate the pharmacy EPD the mean
overall And now and that I dynamics of market distribution temporary think stabilize ceased market outlets and the so terms so, that expanded as channel distributions rate those one is the and I at pharmacies will has in of forth. channels, think
business we Russia market X.X% created And this in that it and X% that a little is, to in healthier. have that’s without Russian. So the in temporarily and disruption that’s looks been ranges
when distributors Mexico. power small where there’s a got in of would little have consolidate. I impacting overall little the issue a more of biggest we hardly consolidate growth you negotiating makes and The be Mexico It’s So, and maybe the then say But that quarter disruption EPD. screen to that seen honest forth. global was a radar a distributors And couple one so Russia. dynamic this in been
see impacting I quarter. numbers think will still we the next
think see And turn. So, we'll kind then say to quarter. a we're I'd at impact it I the probably look to given same next the Russia particularly start going of number
